Insulet (PODD) Misses Q4 EPS by 2c

Insulet (NASDAQ: PODD) reported Q4 EPS of $1.44, $0.02 worse than the analyst estimate of $1.46. Revenue for the quarter came in at $783.8 million versus the consensus estimate of $768.59 million.

For earnings history and earnings-related data on Insulet (PODD) click here.

You May Also Be Interested In

• Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (
• Ashland said to explore sale amid takeover interest - Bloomberg
• MetaVia Inc. (MTVA) Tops Q2 EPS by 73c